204 related articles for article (PubMed ID: 17261087)
1. The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin.
Nakagawa T; Akaki J; Satou R; Takaya M; Iwata H; Katsurada A; Nishiuchi K; Ohmura Y; Suzuki F; Nakamura Y
Biol Chem; 2007 Feb; 388(2):237-46. PubMed ID: 17261087
[TBL] [Abstract][Full Text] [Related]
2. A continuous fluorescence assay of renin activity.
Wang GT; Chung CC; Holzman TF; Krafft GA
Anal Biochem; 1993 May; 210(2):351-9. PubMed ID: 8512070
[TBL] [Abstract][Full Text] [Related]
3. Modification of the substrate specificity of porcine pepsin for the enzymatic production of bovine hide gelatin.
Galea CA; Dalrymple BP; Kuypers R; Blakeley R
Protein Sci; 2000 Oct; 9(10):1947-59. PubMed ID: 11106168
[TBL] [Abstract][Full Text] [Related]
4. Cloning, characterization and site-directed mutagenesis of canine renin.
Bukhtiyarov Y; Zecher M; Panemangalore R; Wu Z; Bruno JG; Yuan J; Xu Z; Dillard LW; McGeehan GM; Harrison RK; Scott BB
J Biochem; 2007 Dec; 142(6):671-80. PubMed ID: 17942478
[TBL] [Abstract][Full Text] [Related]
5. Roles of His9 (P2 subsite) and His13 (P3' subsite) in angiotensinogen for catalytic reaction of renin.
Nabi AH; Uddin MN; Nakagawa T; Orihashi T; Ebihara A; Iwasawa A; Nakamura Y; Suzuki F
Int J Mol Med; 2005 Jul; 16(1):103-7. PubMed ID: 15942685
[TBL] [Abstract][Full Text] [Related]
6. Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions.
Paschalidou K; Neumann U; Gerhartz B; Tzougraki C
Biochem J; 2004 Sep; 382(Pt 3):1031-8. PubMed ID: 15233625
[TBL] [Abstract][Full Text] [Related]
7. Peptide inhibitors of renin in cardiovascular studies.
Haber E
Fed Proc; 1983 Dec; 42(15):3155-61. PubMed ID: 6196232
[TBL] [Abstract][Full Text] [Related]
8. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
[TBL] [Abstract][Full Text] [Related]
9. Palladium(II) complex as a sequence-specific peptidase: hydrolytic cleavage under mild conditions of X-Pro peptide bonds in X-Pro-Met and X-Pro-His segments.
Milović NM; Kostić NM
J Am Chem Soc; 2003 Jan; 125(3):781-8. PubMed ID: 12526679
[TBL] [Abstract][Full Text] [Related]
10. The first Sir George Pickering memorial lecture. Which inhibitors will give us true insight into what renin really does?
Haber E
J Hypertens; 1984 Jun; 2(3):223-30. PubMed ID: 6099385
[TBL] [Abstract][Full Text] [Related]
11. An SRLLR motif downstream of the scissile bond enhances enterokinase cleavage efficiency.
Liew OW; Jenny Chong PC; Lim YZ; Ang CX; Amy Lau YC; Yandle TG; Brennan SO
Biochimie; 2007 Jan; 89(1):21-9. PubMed ID: 17097793
[TBL] [Abstract][Full Text] [Related]
12. X-ray analysis at 2.0 A resolution of mouse submaxillary renin complexed with a decapeptide inhibitor CH-66, based on the 4-16 fragment of rat angiotensinogen.
Dealwis CG; Frazao C; Badasso M; Cooper JB; Tickle IJ; Driessen H; Blundell TL; Murakami K; Miyazaki H; Sueiras-Diaz J
J Mol Biol; 1994 Feb; 236(1):342-60. PubMed ID: 8107115
[TBL] [Abstract][Full Text] [Related]
13. Will renin inhibitors influence decision-making in antihypertensive therapy?
Haber E
J Hypertens Suppl; 1985 Nov; 3(2):S71-80. PubMed ID: 3003303
[TBL] [Abstract][Full Text] [Related]
14. The 2.0 A crystal structure and substrate specificity of the KDEL-tailed cysteine endopeptidase functioning in programmed cell death of Ricinus communis endosperm.
Than ME; Helm M; Simpson DJ; Lottspeich F; Huber R; Gietl C
J Mol Biol; 2004 Mar; 336(5):1103-16. PubMed ID: 15037072
[TBL] [Abstract][Full Text] [Related]
15. Identification of the five essential histidine residues for peptidylglycine monooxygenase.
Yonekura H; Anzai T; Kato I; Furuya Y; Shizuta S; Takasawa S; Okamoto H
Biochem Biophys Res Commun; 1996 Jan; 218(2):495-9. PubMed ID: 8561784
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of recombinant Drosophila Copia aspartic proteinase.
Athauda SB; Yoshioka K; Shiba T; Takahashi K
Biochem J; 2006 Nov; 399(3):535-42. PubMed ID: 16813567
[TBL] [Abstract][Full Text] [Related]
17. Preparation of recombinant thioredoxin fused N-terminal proCNP: Analysis of enterokinase cleavage products reveals new enterokinase cleavage sites.
Liew OW; Ching Chong JP; Yandle TG; Brennan SO
Protein Expr Purif; 2005 Jun; 41(2):332-40. PubMed ID: 15866719
[TBL] [Abstract][Full Text] [Related]
18. Effects of substitution of Val for Leu11 of ovine angiotensinogen on renin activity.
Inui Y; Orihashi T; Okada E; Nakagawa T; Ebihara A; Suzuki F; Nakamura Y
Biosci Biotechnol Biochem; 1998 Nov; 62(11):2267-9. PubMed ID: 9972250
[TBL] [Abstract][Full Text] [Related]
19. Ser84 of human renin contributes to the biphasic pH dependence of the renin-angiotensinogen reaction.
Iwata H; Nakagawa T; Nishiuchi K; Hiratsuka T; Satou R; Yoshioka Y; Fukui Y; Suzuki F; Nakamura Y
Biosci Biotechnol Biochem; 2007 May; 71(5):1279-85. PubMed ID: 17485830
[TBL] [Abstract][Full Text] [Related]
20. Renin cleavage of a human kidney renin substrate analogous to human angiotensinogen, H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Ser-OH, that is human renin specific and is resistant to cathepsin D.
Poe M; Wu JK; Lin TY; Hoogsteen K; Bull HG; Slater EE
Anal Biochem; 1984 Aug; 140(2):459-67. PubMed ID: 6385771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]